Caribou Biosciences logo

Caribou Biosciences

Caribou Biosciences is a Berkeley, California—based private biopharmaceutical company founded in 2011 by Jennifer Doudna and Rachel Haurwitz.

7

Funding Rounds

$489.4m

Money raised

Overview

Caribou Biosciences is a Berkeley, California—based private biopharmaceutical company founded in 2011 by Jennifer Doudna and Rachel Haurwitz.

Funding

Funding series

Funding Series Analysis

The company Caribou Biosciences has raised a total of $319m in funding over 7 rounds.

Key Insights:

  • Caribou Biosciences Series A round: $15m
  • Caribou Biosciences Initial public offering (IPO): $304m
  • Caribou Biosciences Series A Funding Round March 2015: $11m
  • Caribou Biosciences Venture Funding Round September 2014: $2.9m
  • Caribou Biosciences Series C round, March 2021: $115m
  • Caribou Biosciences Series B round, May 2016: $30m
  • Caribou Biosciences Venture round, September 2014: $11.5m
Caribou Biosciences logo
Caribou Biosciences Series A round $15m
Caribou Biosciences logo
Caribou Biosciences Initial public offering (IPO) $304m
Caribou Biosciences logo
Caribou Biosciences Series A Funding Round March 2015 $11m
Caribou Biosciences logo
Caribou Biosciences Series C round, March 2021 $115m
Caribou Biosciences logo
Caribou Biosciences Series B round, May 2016 $30m
Caribou Biosciences logo
Caribou Biosciences Venture round, September 2014 $11.5m
Caribou Biosciences logo
Caribou Biosciences Venture Funding Round September 2014 $2.9m

Industries

Caribou Biosciences is active in the following industries:
  • Agriculture
  • Therapeutics
  • Genetic engineering
  • Agricultural biotechnology
  • Agricultural technology (AgTech)
  • Biomedical engineering
  • Biopharmaceutical
  • Genome editing
  • Cell therapy
  • Medical diagnostics
  • Engineering
  • Technology
  • Synthetic biology
  • Biology
  • Biotechnology
  • Healthcare
  • Regenerative medicine
  • Genomics
  • Tissue engineering
  • Allogeneic cell therapy
  • Immunotherapy